EVGN - Evogene Ltd.

0.761
-0.016   -2.089%

Share volume: 48,366
Last Updated: 05-12-2026
Chemicals/Agriculture Chemicals: -0.08%

PREVIOUS CLOSE
CHG
CHG%
$0.78
-0.02
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
6%
Profitability 0%
Dept financing 6%
Liquidity 50%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.24%
1 Month
-7.17%
3 Months
-20.73%
6 Months
-36.05%
1 Year
-37.62%
2 Year
11.76%
Key data
Stock price
$0.76
P/E Ratio 
0.00
DAY RANGE
$0.75 - $0.80
EPS 
-$0.76
52 WEEK RANGE
$0.72 - $2.42
52 WEEK CHANGE
-$37.62
MARKET CAP 
16.642 M
YIELD 
N/A
SHARES OUTSTANDING 
5.058 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-22-2025
BETA 
0.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$63,706
AVERAGE 30 VOLUME 
$50,931
Company detail
CEO: Ofer Haviv
Region: US
Website: evogene.com
Employees: 140
IPO year: 2008
Issue type: Common Stock
Market: XNAS
Industry: Chemicals/Agriculture Chemicals
Sector: Manufacturing

Evogene Ltd. focuses on product discovery and development in multiple life-science based industries, including human health and agriculture. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer.

Recent news